cisplatin

Cisplatin is a "first generation" antitumor drug highly effective in the chemotherapy of many forms of cancer. Thge metallodrug is most commonly used to treat testicular, bladder, lung, gullet (oesophagus), stomach and ovarian cancers. The water-soluble platinum complex, after hydrolysis, reacts with the nucleic acid bases of DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.
 
IUPAC name: cis-diamminedichloroplatinum(II).



The term "cisplatin" was found in the following pages:

Link database: ChemCases: Cisplatin: The Invention of an Anticancer Drug
Link database: DrugBank: Oxaliplatin
Brief summary: Speciation analysis for the study of metallodrugs and their biomolecular interactions | EVISA's News
Link database: Chemocare: Cisplatin
Link database: Austria: University of Vienna: Institute of Inorganic Chemistry: Working group of B. Keppler
Link database: Lipoplatin -
Link database: Australia: University of Western Sydney: Biologically Active Drugs by Design Group
Species transformation during speciation analysis | EVISA's News
Metallomics 2011: Chemiker der Universität Münster laden zu Symposium über die Rolle von Metallen in Biologie und Medizin ein | EVISA's News
Copper molecule shows promise in fighting against cancer | EVISA's News
Link database: Speciation, bioavailability and antigenotoxicity of Selenium species present in Selenium enriched natural products.
Spatially resolved speciation analysis: A new technique based on laser ablation with simultaneous elemental and molecular mass spectrometry | EVISA's News
Link database: National Cancer Institute: Cisplatin
„Forever young“ oder wirklich jung? - Metallomics im Fokus der Biochemie | EVISA's News
Dartmouth researchers find that arsenic triggers unique mechanism in rare leukemia | EVISA's News
Nanoscale Metal-Organic Frameworks (NMOFs): A new way to create better MRI Contrast Agents | EVISA's News
Chemical speciation analysis for the life sciences | EVISA's News
Ultra-sensitive speciation analysis of inorganic platinum-chloride complexes in platinum-based drugs by HPLC-ICP-MS | EVISA's News
Link database: Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins
Scientific publications with participation of EVISA | EVISA's News